BioCentury
ARTICLE | Financial News

Cel-Sci completes direct public offering

November 3, 2014 8:00 AM UTC

Cel-Sci Corp. (NYSE-M:CVM), Vienna, Va. Business: Cancer, Infectious Date completed: 2014-10-21 Type: Direct public offering Raised: $1 million Shares: 1.3 million Price: $0.76 Shares after offering: ...